INSIDER · CIK 1120477
Patel Dinesh V Ph D
President and CEO, Director at Protagonist Therapeutics, Inc (PTGX)
↗5 Form 4 rows in the window
Covers original filings from Jul 31, 2026 to Oct 28, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$33.1MSold on the market
1Companies
Sep 10, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 202621:17 | Sep 10, 2026from Sep 8, 2026 | PTGXProtagonist Therapeutics, Inc | President and CEO, Director | S · Sell10b5-1 | $145.92 | −125,000 | 522,968 | -19% | −$18.2M | ||
| Sep 10, 202621:17 | Sep 10, 2026from Sep 8, 2026 | PTGXProtagonist Therapeutics, Inc | President and CEO, Director | M · Exercise10b5-1 | $21.58 | +125,000 | 530,246 | +31% | $2.7M | ||
| Sep 8, 202617:14 | Sep 3, 2026 | PTGXProtagonist Therapeutics, Inc | President and CEO, Director | G · GiftLate 5d | — | −510 | 522,968 | -0% | — | ||
| Aug 12, 202618:43 | Aug 11, 2026from Aug 10, 2026 | PTGXProtagonist Therapeutics, Inc | President and CEO, Director | S · Sell10b5-1 | $148.91 | −100,000 | 523,478 | -16% | −$14.9M | ||
| Aug 12, 202618:43 | Aug 11, 2026from Aug 10, 2026 | PTGXProtagonist Therapeutics, Inc | President and CEO, Director | M · Exercise10b5-1 | $21.58 | +100,000 | 557,717 | +22% | $2.2M |